Introduction
From a statistical point of view, in order to achieve a higher power of detection, sample size should be increased. For many experimental situations, it is not always feasible to increase the number of subjects studied. When the event under consideration is rare as to cause appreciable scoring error, then an alternative would be to enhance the precision of each measurement. For example, in the rodent erythrocyte micronucleus assay, the evaluation of 2000 immature erythrocytes per animal and 5 animals per dose group represents commonly cited minimum values. Owing to the rarity of micronucleated cells, even this minimal assay design results in tedious and time-consuming efforts. The use of flow cytometry (1) (2) (3) realizes the ability to evaluate high numbers of erythrocytes, something that is impossible to achieve by manual microscopy. By reducing scoring error in this manner, flow cytometry has the potential to increase statistical power.
In the present study, we evaluated the relationship between statistical power to detect a rare erythrocyte sub-population, i.e. micronucleated or malaria-infected erythrocytes (MN/Mal), and the total number of erythrocytes analysed. These experiments were accomplished using a reconstruction model whereby known quantities of malaria-infected erythrocytes were added to blood from an untreated mouse. Malaria is a known model for micronucleated erythrocytes, as they endow the target cells of interest with a micronucleus-like DNA content (4, 5) . The samples were analysed by flow cytometry to measure the MN/Mal frequency through the interrogation of 2000 (2k), 20 000 (20k), 200 000 (200k) and 1 000 000 (1m) erythrocytes. The results presented here show the capability of flow cytometric technology to reduce scoring error, and also the extent to which this affects the ability to detect small changes to baseline micronucleus frequencies.
Materials and methods
Staining of blood specimens Methanol-fixed blood from untreated and malaria-infected mice used in this study were two 'biological standards' which accompany the Mouse MicroFlowÒPLUS kits (Litron Laboratories, NY). MicroFlow PLUS kits were the source of these specimens.
Before analysis, malaria-infected specimens and untreated mouse specimens were washed out of fixative with $12 ml Hank's Balanced Salt Solution. Procedures for the 3-colour labelling technique which appear in the MicroFlowÒPLUS instruction manual (version 031230) were scaled up $7-fold in order to provide at least 10 ml each of control and malaria blood in a cell density range that is recommended for this assay (between $2000 and 6000 events/s). Anti-CD71-FITC, anti-CD61-PE and all other flow cytometry reagents were also supplied in the kits. After the labelling procedures were accomplished, the cell density of the malaria-infected sample was adjusted so that it was equal to that of the control blood sample. Initial cell densities were measured with a Coulter Counter, model ZM. After adjustment with additional propidium iodide staining solution, equal cell densities were confirmed by Coulter Counter measurements. Normalization of cell densities was an important experimental design consideration, as this allowed us to calculate the expected MN/Mal frequencies in the diluted samples once the frequencies of the original control (0.10 and 0.09% for Experiments 1 and 2, respectively) and malaria-infected (0.67 and 0.70% for Experiments 1 and 2, respectively) samples were determined with high precision (i.e. control and malariainfected %MN/Mal frequencies are the mean value of triplicate analyses with 1m erythrocytes per analysis).
Dilution of malaria blood specimen
Malaria-infected blood (Sample H) was diluted with control blood (Sample A) in the following ratios (v/v): 1:1 (Sample G), 1:3 (Sample F), 1:7 (Sample E), 1:15 (Sample D), 1:31 (Sample C) and 1:63 (Sample B). These blood specimens were stored at 4 C until flow cytometric analysis, which occurred on the same day. Each sample was analysed three times to evaluate reproducibility.
Flow cytometric analysis
All samples were analysed according to the MicroFlowÒ PLUS 3-colour technique. One deviation to the kit-supplied data acquisition and analysis template was that the frequency of erythrocytes with malaria or micronuclei was determined without restriction to CD71-expression level. That is, the Mal and MN frequencies measured and reported here are based on total peripheral blood erythrocytes. A second deviation from standard practices is that the default stop mode of 20 000 reticulocytes was not utilized. Rather, each specimen was analysed until the following number of erythrocytes were acquired: 2k, 20k and 200k erythrocytes in the first experiment and 2k, 20k, 200k and 1m erythrocytes in the second experiment.
Statistical analysis
The average of triplicate MN/Mal measurements associated with the control blood sample were compared with those associated with each of the other seven specimens by the Fisher's exact method. A P-value of 0.05 divided by 7 (number of sample groups) was considered evidence of a statistically significant difference. Expected versus observed MN/Mal frequencies were graphed for each measurement performed in the second experiment. Microsoft Excel (Microsoft Corp., Seattle, Washington) was used to determine a best-fit line. The associated equations and r 2 values were determined.
Results
Data from Experiments 1 and 2 are summarized in Table I and include the expected and observed MN/Mal frequencies. The MN/Mal frequencies shown are the average of triplicate analyses. As shown in Table I , for measurements based on 2k erythrocytes, samples with expected MN/Mal frequencies of 0.39 and 0.24% were found to be significantly different from control samples, in Experiments 1 and 2, respectively. These values correspond to fold increases of 3.9 and 2.7 for the first and second experiment, respectively. As more erythrocytes were analysed per sample, the detection limit was improved. For instance, measurements based on the evaluation of 200k erythrocytes per analysis show statistical significance for expected MN/Mal samples of 0.12 and 0.11%. These values correspond to an increase of $1.2-fold. In fact for the second experiment, when a stop mode of 1m erythrocytes was investigated, statistical significance was observed between the control blood sample (0.09% MN/Mal) and the specimen with the lowest frequency of malaria (0.10% MN/Mal; P 5 0.00005).
As an aid for visualizing the performance characteristics associated with the various number of cells analysed, scattergrams showing %MN/Mal measurement are presented (Fig. 1) .
Best-fit lines and equations are included with these graphs, and illustrate the degree to which the experimentally derived data agree with the linear relationship that is known to exist among MN/Mal frequencies for these specimens.
Discussion
To evaluate the performance and statistical power of a flow cytometric approach to score micronucleated erythrocytes, we performed a reconstruction model experiment by the serial dilution of malaria-infected mouse blood with normal mouse blood. As expected, the present results illustrate that the power of rare event detection is directly related to the number of cells analysed per specimen. By analysing 3m (triplicate of 1m) cells per group, 0.10% is significantly different (P 5 0.00005) when compared with 0.09%. Even so, it must be appreciated that the biological significance of minute changes must be considered in addition to statistical significance.
Previously, we have shown that individual differences were negligible in the mouse micronucleus assay when 1000 cells per animal and 5 or 6 mice per dose group were analysed (6) (7) (8) and the statistical unit for the evaluation can be assigned to a cell but not to an animal. According to the present results and also results by Asano et al. (9) , the variability of the data was high when 2k cells were analysed. Under these circumstances, the difference among animals is not apparent, as they are likely to be smaller than the scoring error. While, in the case of the present malaria dilution experiments, when 200k or 1m cells per sample were analysed, the scoring error decreased and converged to a value. This, however, is not true in the case of the actual micronucleus assays using model chemicals (9) . When 200k or 1m immature erythrocytes were analysed, differences between individual animals became apparent and there was data variability within each dose group. Therefore, even if the experimental size in the animal experiments is increased, we cannot expect the same increment of detecting power. This finding suggests that optimizing the statistical procedure also includes evaluating individual differences.
Based on the present results, we confirm the accuracy and high performance of the micronucleus assay system using flow cytometry and we propose that the number of reticulocytes analysed for the micronucleus assay using flow cytometry be a minimum of 20k. We suggest that the analysis of 20k reticulocytes is approximately equivalent to the manual microscopic analysis according to test guideline OECD 474 (9, 10) . We anticipate that the experimental size of the MN assay will be recommended and set by expert committees based on the evaluated data. In addition to statistical sensitivity, biological variability between animals and as a consequence of treatment should also be considered. There appears to be diminishing value to analyses based on 200k or even 1m per animal. These may be useful in certain special circumstances, for instance when looking for evidence of threshold or practical threshold effects (9) .
